About CerSci Therapeutics
CerSci Therapeutics develops CER-1000, a TRPV4 ion channel antagonist targeting acute post-surgical pain with a non-opioid, non-NSAID mechanism of action.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to CerSci Therapeutics. Response typically within 48 hours.
